In addition, the ISG15-mediated decrease in tumor weight was less profound in athymic C57 nude mouse model when compared to the immuno-competent C57BL/6 mouse model, suggested that the difference in the immune landscape, particularly the absence of T lymphocytes in the C57 nude mouse model, modulated the tumor suppressive effects of ISG15. This evidence concerns the gene ISG15 and neoplasm.